Martek Biosciences plans appeal of E.U. ruling on infant formula patent - St. Louis Business Journal:

mesiaipuhuni1981.blogspot.com
That was word from the Columbia compant Tuesday in regulatory The patent office inthe Hague, Netherlands upheld a patent that was granted to the biotechh firm in 2007 but was challenged by food manufacturers and Ltd. The patenft office said Martek’s patent appliees to Martek’s nutritional oil in infant formula, but is not coverex when it is blended with certain fish oils used ininfantt formula. Martek (NASDAQ: MATK) expecte the appeal will take one to two yearsz and said it does not believe the rulinbg will impactits revenue.
Derived from the company’s nutritional oils are also used in dietarg supplements andfood products, such as yogurt and The company has been aggressively expanding its infant formulsa business overseas as it has nearlg saturated the U.S. market. Martek warned in its last earnings statement that its infanrt formula sales in the third and fourth quarterx could drop as retailers trim theier inventories ofthe product. The company anticipates demand will pick up infiscak 2010.